Archive for the ‘commentary’ Category

[koko] the Ides of March 2020

Sunday, March 15th, 2020

“Genghis Khan and his brother Don
Could not keep on keepin’ on”
(1971) “You Ain’t Goin’ Nowhere” – Bob Dylan

In spite of the pandemic, I feel blessed today. Blessed that my mother was a public health nursing professor, who taught me hygiene and many other useful practices especially useful now. Blessed that my father was a public health statistician, that my sister is a family practice physician, that my graduate studies and early professional life engaged me in probability, modeling, and simulation. I feel better prepared than many to understand and adjust to this new reality.

COVID spread graph


koko: Tuesday’s measurement of our electorate

Friday, November 11th, 2016

An attempt at organizing thoughts & readings

Tuesday (and early voting in the weeks before) was a measurement, and though decisive, not a very complete or illuminating diagnosis of our population, any more than taking a person’s temperature characterizes their health. Our electoral health is not good. (more…)

Red Arco Iris as a teenager

Monday, April 6th, 2009

Red Arco Iris (en Inglés, Rainbow Network) is coming of age and has much to celebrate. From Keith and Karen Jaspers’ vision 15 years ago to today, much has been accomplished.


another 15KM walk

Sunday, March 29th, 2009


Today was another Capitol 10K. Not a lot different from last year, about 15KM from parking to getting back in the car, a little under 3 hours total this year, about 103.5 minutes on the race clocks, so about 100 minutes, just over 16 minutes/mile, after subtracting for pit stops. (My mental model was to stay with the peloton which maybe I did.)

This year’s cell phone photos are below.


AVSR vs. MSFT: numbers of patents or patent numbers?

Tuesday, June 3rd, 2008

Yesterday, Avistar issued a press release: Fourteen of Microsoft Re-examination Challenges of Avistar’s U.S. Patents Rejected by U.S. Patent Office. Various reports followed, counting nine re-exam requests that had been determined for re-exam by the U.S. PTO, e.g., Avistar 14, Microsoft 9 in patent re-examination battle; shares jump. Since there were a total of 29 reported filings by Microsoft, that appears to leave six requests that have neither been rejected nor determined for re-exam. (The reported 21 cent jump in AVSR share price from below a dollar to $1.18, might actually be the biggest news, given the NASDAQ ramifications of share prices less than a dollar.)